|2.||Ovarian Neoplasms (Ovarian Cancer)
|3.||Breast Diseases (Breast Disease)
|5.||Dysmenorrhea (Menstrual Pain)
|1.||Yang, Shun-Fa: 15 articles (01/2015 - 01/2008)|
|2.||Wang, Po-Hui: 15 articles (01/2015 - 01/2008)|
|3.||Tsai, Hsiu-Ting: 14 articles (01/2015 - 01/2008)|
|4.||Ness, Roberta B: 14 articles (11/2014 - 05/2002)|
|5.||Tee, Yi-Torng: 11 articles (01/2015 - 01/2008)|
|6.||Lin, Long-Yau: 10 articles (01/2015 - 01/2008)|
|7.||Haggerty, Catherine L: 8 articles (11/2014 - 01/2003)|
|8.||Peipert, Jeffrey F: 7 articles (02/2010 - 08/2004)|
|9.||Soper, David E: 7 articles (02/2008 - 05/2002)|
|10.||Randall, Hugh: 6 articles (02/2008 - 05/2002)|
|1.||Anti-Bacterial Agents (Antibiotics)IBA
01/01/2007 - "[Efficacy of intraosseous administration of antibiotics in the treatment of pelvic inflammatory diseases in women]."
08/15/1987 - "Efficacy of different antibiotics in the treatment of pelvic inflammatory disease."
08/01/1999 - "A more important finding in these trials is the low incidence of pelvic inflammatory disease with or without prophylactic antibiotics. "
07/01/1986 - "A follow-up study was undertaken in 493 women who had participated in a clinical, controlled trial with the object of assessing the role of postabortal pelvic inflammatory disease and prophylactic antibiotics in the development of sequelae. "
06/01/2015 - "We present a case of 22-years-old patient initially treated with antibiotics under diagnosis of pelvic inflammatory disease. "
|2.||Doxycycline (Vibramycin)FDA LinkGeneric
05/01/2013 - "To evaluate the efficacy of placentrex injection along with oral doxycycline against oral doxycycline in pelvic inflammatory diseases, a comparative study was undertaken among two groups of patients comprising 60 in each at Pt BD Sharma Postgraduate Institute of Medical Sciences, Rohtak during the period April 2010 to April 2012. "
11/15/1983 - "Prevention of acute pelvic inflammatory disease after hysterosalpingography: efficacy of doxycycline prophylaxis."
10/01/1994 - "Two double-blind randomized studies conducted in Africa comparing a 200 mg prophylactic dose of doxycycline with a placebo did not conclusively identify a reduced risk of post-insertion pelvic inflammatory disease (PID). "
06/01/2011 - "Side effects of doxycycline in adolescents treated for pelvic inflammatory disease."
12/01/2002 - "In this case report, a 33 year old female patient who had been prescribed doxycycline for pelvic inflammatory disease is presented. "
|3.||Clindamycin (Cleocin)FDA LinkGeneric
09/01/1992 - "It also can be administered in combination with a drug such as clindamycin for treatment of pelvic inflammatory disease or postoperative pelvic infections."
01/03/1981 - "Patients with endometritis or adnexitis usually received clindamycin in combination with an aminopenicillin. "
02/01/1986 - "Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin."
05/01/1986 - "Forty-two patients with acute pelvic inflammatory disease were treated using aztreonam, a monobactam, and clindamycin. "
05/01/1986 - "Treatment of acute pelvic inflammatory disease with aztreonam, a new monocyclic beta-lactam antibiotic, and clindamycin."
|4.||Cefoxitin (Cefoxitin Sodium)FDA LinkGeneric
04/01/1988 - "This study suggests that the combination of cefoxitin and doxycycline is effective for ambulatory treatment of pelvic inflammatory disease."
10/29/1983 - "Efficacy of ampicillin and cefoxitin in the treatment of acute pelvic inflammatory disease. "
10/01/2008 - "Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease."
02/01/2008 - "genitalium has been associated with treatment failure following cefoxitin and doxycycline treatment for clinically suspected pelvic inflammatory disease. "
01/01/1997 - "Ampicillin/Sulbactam vs. Cefoxitin for the treatment of pelvic inflammatory disease."
|5.||Ciprofloxacin (Cipro)FDA LinkGeneric
01/01/1988 - "Oral ciprofloxacin-monotherapy proved to be safe and effective in pelvic inflammatory disease."
01/01/1988 - "The study showed clinical efficacy of orally administered ciprofloxacin in pelvic inflammatory disease."
11/30/1989 - "Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin."
08/01/2008 - "Pelvic inflammatory disease with Tc-99m ciprofloxacin imaging."
10/01/2000 - "Imaging pelvic inflammatory disease with Tc-99m ciprofloxacin."
|6.||Ofloxacin (Levofloxacin)FDA LinkGeneric
01/01/1995 - "Ofloxacin appears to be effective therapy for pelvic inflammatory disease, without the need for additional anaerobe cover. "
01/01/1999 - "To evaluate the safety and efficacy of intravenous and oral ofloxacin monotherapy in the treatment of laparoscopically documented acute pelvic inflammatory disease (PID). "
10/01/1993 - "In a double-blind stratificated, placebo controlled study the efficacy and safety of a single oral dose of ofloxanin (Tarivid) (400 mg) in preventing postabortal pelvic inflammatory disease (P-PID) in women with induced first-trimester abortions were assessed. "
09/01/2003 - "Psychiatric side effects of ofloxacin used in the treatment of pelvic inflammatory disease."
09/01/2006 - "Pancytopenia with levofloxacin therapy for pelvic inflammatory disease in an otherwise healthy young patient."
01/05/1990 - "Studies have shown that oral contraceptive use may protect against pelvic inflammatory disease (PID), but it is not known whether oral contraceptives protect against the disease among women already infected with Chlamydia trachomatis or Neisseria gonorrhoeae. "
11/15/1982 - "To study the association of the use of oral contraceptives (OCs) and pelvic inflammatory disease (PID), the US Centers for Disease Control analyzed data from the Women's Health Study, a large multicenter case-control study of contraceptive use and serious gynecologic disorders; it included data from interviews of 648 women hospitalized with an initial episode of PID and 2516 hospitalized control subjects. "
11/15/1982 - "To study the association of the use of oral contraceptives and pelvic inflammatory disease (PID), we analyzed data from a large multicenter case-control study of contraceptive use and serious gynecologic disorders. "
12/01/2001 - "As with oral contraceptives, the risk of pelvic inflammatory disease is reduced, because of reduced menstrual blood loss, endometrial suppression, and thickening of the cervical mucus. "
01/01/1991 - "A case-control analysis of hospital-based data was conducted to evaluate whether low-dose combination oral contraceptives (OCs) protect against pelvic inflammatory disease (PID). "
|8.||Ampicillin (Omnipen)FDA LinkGeneric
10/29/1983 - "Efficacy of ampicillin and cefoxitin in the treatment of acute pelvic inflammatory disease. "
04/17/1987 - "Combination treatment is more than twice as cost-effective as tetracycline and seven times as cost-effective as ampicillin when the medical cost of managing pelvic inflammatory disease is considered. "
10/01/1986 - "Comparison of preventive use of metronidazole and ampicillin in women with a history of pelvic inflammatory disease undergoing first-trimester abortion."
01/01/1986 - "The sulbactam/ampicillin failure was a patient with pelvic inflammatory disease with a positive Chlamydia trachomatis culture who required antichlamydial therapy. "
01/01/1991 - "A total of 30 women with pelvic inflammatory disease, wound infections, vaginitis and puerperal sepsis received an intramuscular combination of sulbactam/ampicillin in a total daily dose of 1.5 g for between 3 and 7 days. "
|9.||Metronidazole (Metric)FDA LinkGeneric
01/01/1983 - "In cases of pelvic inflammatory diseases metronidazole is to be recommended both prophylactically and therapeutically. "
01/01/1992 - "The purpose of this study was to evaluate the effect of metronidazole treatment on the incidence of postoperative pelvic inflammatory disease after first-trimester abortion in women with bacterial vaginosis. "
01/01/1987 - "In a double-blind controlled trial the effect of prophylactic metronidazole on postabortal infection in women with a history of pelvic inflammatory disease (PID) was assessed. "
09/01/2002 - "Metronidazole was provided to 67 (69%) of 97 women with TV because of TV on wet preparation, exposure to TV, or a diagnosis of bacterial vaginosis or pelvic inflammatory disease; however, if TV PCR had been used for diagnosis, 81 (84%) of 97 women with TV would have been treated (P=.02). "
01/01/1992 - "Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study."
|10.||Ceftriaxone (Ceftriaxon)FDA LinkGeneric
07/01/1994 - "This study demonstrated a significant reduction in post-operative pelvic inflammatory disease in low risk patients, who were applying for legal first trimester abortion, treated peroperatively with ceftriaxone. "
03/01/1989 - "Additional studies are required for further elucidation of the role of ceftriaxone in the treatment of pelvic inflammatory disease and syphilis. "
02/01/2015 - "We conducted a phase 3 study to evaluate the efficacy and safety of intravenous MNZ combined with ceftriaxone (CTRX) in Japanese subjects with infectious peritonitis, abdominal abscess or pelvic inflammatory diseases (PIDs) to obtain regulatory approval. "
07/01/1996 - "It was 90.26%, the therapeutic success in the treatment of pelvic inflammatory diseases by Ceftriaxon plus Doxycycline was noted in 90.19% of patients. "
03/01/1996 - "These included ceftriaxone, $8.60 per dose; cefixime, $4.67 per dose; ceftriaxone efficacy, 98% (range, 94.9% to 100%); cefixime efficacy, 97% (94.1% to 100%); and a 15% probability of pelvic inflammatory disease (PID) related to failed treatment. "
|1.||Contraception (Birth Control)
01/01/1980 - "Although the IUD is considered a safe and effective form of contraception, long-term use increases risk of pelvic inflammatory disease (PID), often of proven bacterial origin. "
07/09/1982 - "The protective effect of barrier-method contraception against pelvic inflammatory disease (PID) was examined by analyzing data from the Women's Health Study, a large multicenter case-control study. "
08/01/2007 - "One woman who was assigned to the IUD experienced pelvic inflammatory disease (crude rate, 0.16/100 woman-years; 95% CI, 0.004-868); there was no pelvic inflammatory disease among those women who were assigned to hormonal contraception. "
10/01/2006 - "It is prudent that clinicians provide counseling regarding healthy sexual behaviors, STD prevention, and contraception whenever an adolescent presents in need of STD screening or evaluation for pelvic inflammatory disease."
08/01/2006 - "The risk to IUD users of pelvic inflammatory disease (PID) is similar to women using no contraception (SOR: B). "
|2.||Intrauterine Devices (Intrauterine Device)
04/01/1993 - "Comprehensive, mainly epidemiological data has helped us to recognize the strongest risk factors of pelvic inflammatory disease during intrauterine contraceptive device use. "
12/01/2005 - "To study the microbial characteristics of patients with pelvic inflammatory disease (PID) and the possible impact of an intrauterine device (IUD) on the microbial environment in women presenting with PID. "
09/01/2000 - "Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990."
12/01/1992 - "A World Health Organization prospective randomized study found that there was an increase in pelvic inflammatory disease rates in the first 20 days after intrauterine device insertion. "
10/01/1991 - "The increased risk of pelvic inflammatory disease (PID) among users of an intrauterine device was confirmed in a reanalysis of the Oxford Family Planning Study. "
10/01/2008 - "As demonstrated by our results, 3-week balneotherapy is a potentially useful adjunct for the management of chronic pelvic inflammatory disease, but further, long-term studies are notwithstanding necessary."
04/01/2014 - "One of the remaining seven trials evaluated balneotherapy in chronic inflammatory pelvic diseases, while six studies explored its effect on various laboratory parameters. "
01/01/1970 - "[Results of balneotherapy in cases of disturbed menstrual cycle in the course of adnexitis]."
07/01/1968 - "[Complementary balneotherapy after glucocorticotherapy of adnexitis in sterile women]."
05/01/1952 - "[Balneotherapy of chronic adnexitis]."
06/01/1993 - "The data on hysterectomy are particularly interesting; the operation in women with pelvic inflammatory disease is most often a consequence of the inflammatory process itself."
10/01/1987 - "Total abdominal hysterectomy was commonly performed due to the high rate of chronic pelvic inflammatory disease. "
02/01/1984 - "Extensive surgery for pelvic inflammatory disease was defined as hysterectomy or bilateral adenexal surgery, with pelvic inflammatory disease as the only gynecologic discharge diagnosis. "
01/01/1951 - "[Septicopyemia from Proteus after subtotal hysterectomy for chronic adnexitis]."
01/01/1985 - "Total abdominal hysterectomy and bilateral salpingo-oophorectomy as a treatment for pelvic inflammatory disease should be the exception rather than the rule."